Amoxicillin
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
Treatment of infections due to susceptible (β-lactamase-negative) strains causing the following syndromes:
- Infections of the ear, nose, and throat – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Infections of the genitourinary tract – due to E. coli, P. mirabilis, or E. faecalis.
- Note: empiric use is not recommended by IDSA due to higher rates of resistance to E. coli and poor efficacy[3].
- Infections of the skin and skin structure – due to Streptococcus spp. (α- and β-hemolytic strains), Staphylococcus spp., or E. coli
- Infections of the lower respiratory tract – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to N. gonorrhoeae (males and females). Note: amoxicillin is not recommended by the CDC for the treatment of gonorrhea due to high rates of resistance.
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence in combination with other agents.
Amoxicillin ER tablet (Mmoxtag™) is indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatric patients ≥12 y/o
NON-FDA APPROVED USES
- Lyme disease
- Non-severe Enterococcus infections
- Suppression therapy for prosthetic joint infections caused by streptococci, Enterococcus, C. acne
- Endocarditis prophylaxis
- Dental infections
- Low-risk penicillin allergies; challenge with oral penicillin "direct amoxicillin challenge"[16]
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
Treatment of infections due to susceptible (β-lactamase-negative) strains causing the following syndromes:
- Infections of the ear, nose, and throat – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Infections of the genitourinary tract – due to E. coli, P. mirabilis, or E. faecalis.
- Note: empiric use is not recommended by IDSA due to higher rates of resistance to E. coli and poor efficacy[3].
- Infections of the skin and skin structure – due to Streptococcus spp. (α- and β-hemolytic strains), Staphylococcus spp., or E. coli
- Infections of the lower respiratory tract – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to N. gonorrhoeae (males and females). Note: amoxicillin is not recommended by the CDC for the treatment of gonorrhea due to high rates of resistance.
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence in combination with other agents.
Amoxicillin ER tablet (Mmoxtag™) is indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatric patients ≥12 y/o
NON-FDA APPROVED USES
- Lyme disease
- Non-severe Enterococcus infections
- Suppression therapy for prosthetic joint infections caused by streptococci, Enterococcus, C. acne
- Endocarditis prophylaxis
- Dental infections
- Low-risk penicillin allergies; challenge with oral penicillin "direct amoxicillin challenge"[16]
There's more to see -- the rest of this entry is available only to subscribers.